Bupropion can cause weight loss, though the amount varies widely from person to person. In clinical trials of obese adults, those taking bupropion lost between 7% and 10% of their body weight over 24 weeks, compared to 5% in the placebo group. It’s one of the few antidepressants associated with weight loss rather than weight gain, which is a major reason people ask about it.
Bupropion is FDA-approved for depression, seasonal affective disorder, and smoking cessation. It is not approved as a standalone weight loss drug. However, it is one half of Contrave, an FDA-approved weight loss medication that combines bupropion with naltrexone.
How Bupropion Affects Appetite
Bupropion works by increasing levels of dopamine and norepinephrine in the brain, both of which play a role in regulating appetite. It also stimulates specific neurons in the hypothalamus (the brain’s appetite control center) that release a hormone with natural appetite-suppressing properties. This is a different mechanism than most antidepressants, which primarily target serotonin and tend to increase hunger or cravings over time.
The appetite suppression isn’t dramatic for most people. It’s more of a reduced interest in food or feeling satisfied sooner, rather than a complete loss of hunger. Some people notice this effect within the first few weeks, while others experience it more gradually.
How Much Weight People Actually Lose
The best data comes from a 48-week, double-blind trial of obese adults. At the 24-week mark, people taking bupropion at the standard 300 mg/day dose lost an average of 7.2% of their starting body weight. Those on a higher 400 mg/day dose lost 10.1%. The placebo group lost 5.0%, meaning the drug itself accounted for roughly 2 to 5 percentage points of additional loss.
To put that in practical terms: for someone starting at 200 pounds, bupropion at 300 mg/day contributed about 4 to 5 extra pounds of loss beyond what diet changes alone produced. At the higher dose, the extra loss was closer to 10 pounds.
The results held up over time. People who stayed on bupropion for a full 48 weeks maintained average losses of 7.5% to 8.6% of their initial weight, suggesting the effect doesn’t simply wear off after a few months. In a separate study of women who responded well in the first 8 weeks and continued for 24 weeks total, responders lost an average of 12.9% of their body weight, with about three-quarters of that coming from fat rather than muscle.
Dose Makes a Difference
Higher doses produce more weight loss, but the effect at lower doses is modest. In a trial of depressed outpatients (not specifically studying weight), those on 150 mg/day lost an average of just 0.5 kg (about 1 pound) over the treatment period, compared to 1.0 kg (about 2 pounds) at 300 mg/day. In the obesity-focused trial, the jump from 300 to 400 mg/day made a more noticeable difference, with 83% of people on the higher dose losing at least 5% of their body weight compared to 59% on 300 mg/day.
Most people prescribed bupropion for depression take 150 to 300 mg/day. At those doses, weight loss is a welcome side effect for some but not a guaranteed one.
How It Compares to Other Antidepressants
This is where bupropion really stands apart. Every major SSRI and SNRI antidepressant is associated with weight gain. In a large comparison study, people taking sertraline saw their BMI increase by an average of 0.45 points, and those on fluoxetine gained 0.50 BMI points. People on bupropion, by contrast, saw a slight BMI decrease of 0.02 points. The differences were statistically significant.
Paroxetine, citalopram, escitalopram, and duloxetine all showed significant BMI increases as well. Bupropion was the only antidepressant in the study associated with a weight-neutral to mildly weight-reducing effect. For people switching from an SSRI that caused weight gain, bupropion often helps reverse some of that gain simply by removing the appetite-stimulating medication.
Interestingly, combining bupropion with an SSRI doesn’t preserve the weight benefit. People taking both sertraline and bupropion together gained more weight than those on bupropion alone, with a BMI increase of 0.65 points.
Not Everyone Loses Weight
While weight loss is the more common pattern, a small percentage of people gain weight on bupropion. In placebo-controlled trials, 3% of those taking 300 mg/day gained more than 5 pounds, which was actually lower than the 4% who gained that much on placebo. So weight gain can happen, but it’s less likely on bupropion than on a sugar pill, and far less likely than on other antidepressants. In older studies comparing bupropion to tricyclic antidepressants, only 9% of bupropion users gained weight versus 35% on the older drugs.
When to Expect Results
Weight loss from bupropion typically begins within the first few weeks, with the most noticeable changes happening in the first 8 to 24 weeks. In one study, participants lost an average of 4.9% of their body weight in just the first 8 weeks on bupropion, compared to 1.3% on placebo. The effect continued through 24 weeks and was largely maintained at 48 weeks, though the pace of loss slowed considerably after the initial period.
If you’ve been taking bupropion for three months and haven’t noticed any change in weight or appetite, you’re unlikely to see significant weight loss from the medication going forward. The people who respond tend to show signs early.
Important Safety Considerations
Bupropion carries a higher seizure risk than most antidepressants, and this risk increases with higher doses, rapid dose increases, and certain medical conditions. It is specifically contraindicated for anyone with anorexia nervosa or bulimia nervosa. The electrolyte imbalances and nutritional deficits associated with eating disorders significantly raise the seizure threshold, making bupropion genuinely dangerous in that context.
This matters because someone searching for weight loss medications while also struggling with disordered eating could be at serious risk. Bupropion should never be used as a diet pill, and its weight loss effects are a secondary property of a medication designed primarily to treat depression and help with smoking cessation.